tbuckley/cabot-search huggingface dataset:
The Modern Management of Gastric and Duodenal Ulcer
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Iron deficiency anemia in a vegetarian runner
Authors: M. B. Jacobs
Journal: JAMA (1984)

<h3>In Reply.—</h3> Dr Zucker raises an interesting historical question. It is hard enough agreeing about the interpretation of a recent case; the task is harder in ascertaining the facts about a 2,500-year-old case. Working backward, one rapidly loses the trail of Pheidippides' sudden death. Surprisingly enough, a major source for this popular legend is Robert Browning's<sup>1</sup>magnificent poem. He flung down his shield Ran like fire once more: and the space twixt the fennel field And Athens was stubble again, a field which a fire runs through 'Til in he broke: "Rejoice we conquer!" Like wine through clay, Joy in his blood bursting his heart, he died—the bliss!<sup>2</sup> For some reason, the theme of the hero's sudden death is prominent in many of Browning's other works. As a result, one wonders if the Pheidippides case reflects poetic license as opposed to historical/medical fact. The logical reference to check
Waste
Authors: George D. Lundberg
Journal: JAMA (1986)

He was the best pathology resident I had ever known, before or since that day nine years ago. And that includes hundreds of residents at seven institutions where I have had direct responsibility. He had entered medical school later in life than most, having first become a cytotechnologist, thus acquiring a skill that helped him work his way through medical school. Only three months into his internship, he made a pathology presentation to medical grand rounds at the largest teaching hospital in the United States and received an ovation from the usually cynical crowd. In addition to excelling in every standard rotation in anatomic and clinical pathology, he ran a major course in general and systemic pathology for 150 sophomore pharmacy students as an add-on to his second-year residency duties. He was also an exceptional human being on a personal level. I remember a softball game at a fund-raising Medical
Development of an 125 I-Postlabeling Assay as a Simple, Rapid, and Sensitive Index of DNA-Protein Cross-Links
Authors: Zhixiong Zhuang, Max Costa
Journal: Environmental Health Perspectives (1994)

A rapid, simple, and sensitive 1251-postlabeling technique has been developed to allow detection of DNA-protein cross-links induced by environmental contaminants and carcinogens.This method is based on specific incorporation of 1251 into tyrosine residues associated with DNA.Cultured Chinese hamster ovary cells were exposed to various crosslinking agents, e.g., UV light, K2CrO4, or NiCI2.DNA was isolated by proteinase K/phenol/chloroform.The residual peptides cross-linked to DNA were radioiodinated with Na1251 and chloramine T. After repeated precipitation with ethanol, the radioactivity was determined.The 1251 method was compared with a 3[HI-tyrosine prelabeling method and found to be of similar sensitivity.
Acute melioidosis in a soldier home from South Vietnam
Authors: M. C. Patterson
Journal: JAMA (1967)

A fatal case of acute melioidosis occurred in a soldier who had recently returned from Vietnam.<i>Pseudomonas pseudomallei</i>was identified by culture of blood specimens taken before and after death, animal inoculation, and fluorescent antibody tests. Chloramphenicol is the drug of choice in this disease.
ANALYSIS OF ENDOMYOCARDIAL BIOPSIES IN CARDIOMYOPATHIES: DIAGNOSTIC VALUE ON LEFT VERSUS RIGHT VENTRICULAR BIOPSY
Authors: Felicitas Escher, Dirk Lassner, Uwe Kühl, Dirk Westermann, Tschöpe Carsten, Heinz-Peter Schultheiss
Journal: Journal of the American College of Cardiology (2014)
Housing, health, and illness.
Authors: James Cox, S Thomas
Journal: BMJ (1978)

myocardial infarction so that any arrhythmia that developed could be treated promptly.However, there is evidence that hospital care may actually cause some of the arrhythmias that then have to be treated.More than 20 years ago Dr Klaus Jarvinen' observed that a disproportionate number of patients dying in hospital after acute myocardial infarction did so during or shortly after ward rounds.That interaction with hospitals and staff can significantly affect a patient's heart rate and rhythm is also well documented.2Although no one would suggest that there is no place for specialised coronary care units it is tempting to speculate that they have to be so well equipped and expertly staffed to compensate for the arrhythmias precipitated by the fear and isolation experienced by a patient in hospital.A study comparing the incidence of arrhythmias after myocardial infarction at home and in hospital would be most interesting.
Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Multiple Myeloma among African-American and White Veterans in the U.S.
Authors: Ola Landgren, Gloria Gridley, Ingemar Turesson, Neil E. Caporaso, Lynn R. Goldin, Dalsu Baris, Thomas R. Fears, Robert N. Hoover, Martha S. Linet
Journal: Blood (2005)
THU0295 Clinical features of takayasu's arteritis from an inception cohort: early disease is characterized by “systemic inflammation”
Authors: F Alibaz-Oner
Journal: Annals of the Rheumatic Diseases (2017)

<h3>Background</h3> There is only retrospective and very limited data for the long term prognosis of Takayasu9s Arteritis (TAK), a rare large-vessel vasculitis. In this study, we aimed to present the preliminary results of a Takayasu Inception Cohort settled for long term, prospective follow-up of only newly-diagnosed patients with TAK. <h3>Methods</h3> Patients fullfilling the American College of Rheumatology 1990 criteria for TAK and diagnosed in the last 12 months were included to the study. Patients9 data were recorded in an electronic database of an international “Takayasu9s Arteritis Registry” requiring baseline and at least annual visits. Data is compared with an historical Turkish cohort previously published (Bıçakçıgil, et al, 2009). <h3>Results</h3> The study included 128 patients (age: 38.9±13.1 years, F/M: 112/16) with TAK from 15 tertiary Rheumatology centers in Turkey. The mean symptom duration of patients was 5.2 years at diagnosis. According to the angiographic classification, 59.2% of the study group had type I and only 17.2% had type V disease. When we compared our results to our retrospective cohort (previously published by Turkish Takayasu Arteritis Study Group), constitutional symptoms (72.2% vs 66%) and limb claudication (62.3% vs 48%) were observed to be more frequent, whereas pulselessness (35.6% vs 88%) was less in the inception cohort.(Table 1) Carotidynia was present only in the inception cohort. Similarly, mucocutaneous symptoms also seem to be a feature of newly-diagnosed disease (26.4% vs 8.8%). Regarding comorbidities at diagnosis, the rate of dyslipidemia was 22%, diabetes mellitus 6%, smoking 28.5% and obesity (BMI&gt;30) 15.8% among TAK patients. All patients were given oral corticosteroid (CS) therapy (0.5–1 mg/kg) at diagnosis, 10 patients (7.8%) also having CS pulses. In addition to CSs, 55 patients (43%) were given methotrexate, 14 patients (11%) azathioprine and 5 (4%) cyclophosphomide at disease-onset. <h3>Conclusions</h3> Our results suggest that, in an inception cohort, signs and symptoms of “systemic inflammation” is more prominent in newly-diagnosed TAK patients, whereas vascular extent and damage accumulates during the disease course. The long term follow-up of our inception cohort will better show the actual course and predictors of prognosis in TAK. <h3>Disclosure of Interest</h3> None declared
Committee on Awards
Journal: JAMA (1961)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P
Authors: E. E. Ustinova, D. Bergren, H. D. Schultz
Journal: Cardiovascular Research (1995)

Journal Article Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P Get access Elena E. Ustinova, Elena E. Ustinova * aDepartment of Physiology and Biophysics, University of Nebraska College of Medicine, 600 S 42nd Street, Omaha, NE 68198, USA *Corresponding author. Search for other works by this author on: Oxford Academic PubMed Google Scholar Dale Bergren, Dale Bergren bDivision of Physiology, Department of Biomedical Sciences, Creighton University, Omaha, NE 68178, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Harold D. Schultz Harold D. Schultz aDepartment of Physiology and Biophysics, University of Nebraska College of Medicine, 600 S 42nd Street, Omaha, NE 68198, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Cardiovascular Research, Volume 30, Issue 1, July 1995, Pages 55–63, https://doi.org/10.1016/S0008-6363(95)00010-0 Published: 01 July 1995 Article history Received: 21 October 1994 Accepted: 21 February 1995 Published: 01 July 1995
Masthead
Authors: Paul Berk, New York, Andres Blei, Herbert Bonkovsky, Adrian Bisceglie, St Louis, Michael Gerber, New Orleans, Robert Glickman, Ann Boston, Maryland Hubbard, Willis S A N Francisco, Esteban Dallas, Maryland Baltimore, Jurg Reichen, Allan Wolkoff, Raymond Koff, T Liang, Irwin Arias, Michelle Britton, Kerry Carlyle, John Gollan, D Bissell, Eugene Schiff, Florida Miami, Esteban Mezey, Anthony Tavill, Nicholas Cleveland, Rochester Larusso, Minnesota Kaplowitz, Los Angeles, Michael Sorrell, Jay Hoofnagle, Maryland Bethesda, John Vierling, David Crabb, Scott Friedman, San Francisco, Joseph Bloomer, Minnesota Klein, Glen Arm, Maryland Dienstag, Steven Boston, Anna Antonio, Robert Lok
Journal: Hepatology (1994)
Induction of Adrenal Suppression by Megestrol Acetate
Authors: Sheldon S. Stoffer
Journal: Annals of Internal Medicine (1996)

Letters15 March 1996Induction of Adrenal Suppression by Megestrol AcetateSheldon S. Stoffer, MD and Jesse C. Krakauer, MDSheldon S. Stoffer, MDOakland Internists and Associates; Southfield, MI 48034Search for more papers by this author and Jesse C. Krakauer, MDOakland Internists and Associates; Southfield, MI 48034Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-124-6-199603150-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The recent article by Leinung and colleagues [1] is of great public health importance in showing that megestrol acetate, a progestational agent, can suppress the pituitary-adrenal axis and result in secondary adrenal insufficiency. This information is not currently included in the Physicians' Desk Reference and remains largely unknown to prescribing physicians.We describe a 52-year-old woman who was referred for possible adrenal insufficiency. She had had lumpectomy in 1988, followed by radiation therapy and chemotherapy for breast cancer. Because a bone scan suggested involvement of vertebrae T11 and L1, the patient received radiation therapy to the back ...REFERENCE1. Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med. 1995; 122:843-5. Google Scholar Author, Article, and Disclosure InformationAuthors: Sheldon S. Stoffer, MD; Jesse C. Krakauer, MDAffiliations: Oakland Internists and Associates; Southfield, MI 48034 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight lossPhase II study of high-dose megestrol acetate in platinum-refractory epithelial ovarian cancerA comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight lossMegestrol acetate therapy and secondary adrenal suppressionDose-Response Trial of Megestrol Acetate in Advanced Breast Cancer: Cancer and Leukemia Group B Phase III Study 8741 15 March 1996Volume 124, Issue 6Page: 613-614KeywordsCortisolDrugsEndocrine therapyFood and Drug AdministrationForecastingLumpectomyPituitary tumorsPrevention, policy, and public healthRadiation therapyVertebrae ePublished: 15 August 2000 Issue Published: 15 March 1996 Copyright & PermissionsCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/cyclophosphamide (AC)→paclitaxel (T) vs. AC→T with trastuzumab (H)
Authors: C. E. Geyer, J. L. Bryant, E. H. Romond, M. S. Ewer, D. L. Keefe, R. P. Shannon, T. B. Levine, P. Rastogi, S. M. Swain, N. Wolmark
Journal: Journal of Clinical Oncology (2006)

581 Trastuzumab (H) has been shown to improve 3-year disease-free survival (DFS) and overall survival (OS) in HER2 positive, node-positive breast cancer patients when combined with paclitaxel (T) following AC (Romond NEJM 2005:353;1673–1684). Cardiac dysfunction is the major toxicity associated with the addition of H to AC→T. The 3-year cumulative incidence of cardiac events (class III/IV CHF or cardiac death) with AC→TH was 4.1% compared to 0.8% with AC→T (Tan-Chiu JCO 2005:23;7811–7819). An updated analysis of cardiac safety on B-31 with an additional full year of follow-up is planned for March 2006 and will be presented. [Table: see text]
Directory of Medical Specialists Certified by American Boards, 1942. Published for the Advisory Board for Medical Specialties
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Transesophageal Echocardiography
Authors: Werner G. Daniel, Andreas Mügge
Journal: New England Journal of Medicine (1995)

During the past two decades, cardiovascular ultrasonography has benefited from technical innovations that have allowed it to become a cornerstone of the modern diagnosis of cardiac disease. Transesophageal echocardiography (TEE) is one of the more recent developments. In the past few years clinical applications of TEE have grown explosively. In this article, we summarize the present status and diagnostic value of TEE as compared with transthoracic echocardiography, emphasizing in particular the effect of TEE on diagnostic decision making and patient care.In 1976, Frazin et al. described their initial experience with a single-crystal ultrasound transducer attached to a coaxial cable . . .
Love Fills a Chair, Not Whole School.
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Wrong Name in Signature
Journal: JAMA (1981)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Specific Congenital Defect of Brain (Arhinencephaly) in 13-15 Trisomy
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pedacius Dioscorides
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Retreatment of chronic hepatitis B (CH HBV) with alpha 2 interferon (IFN) in nonresponders and relapse patients is efficient *Service d'H�pato-gastroent�rologie et **Service de Virologie; CHU Toulouse-Purpan 31059 Toulouse Cedexm ***Service de M�decine Interne A, CHJ Toulouse-Rangueil 31054 Toulouse Cedex-France
Journal: Hepatology (1995)